Clinical Trials Directory

Trials / Conditions / Primary Central Nervous System Hodgkin Lymphoma

Primary Central Nervous System Hodgkin Lymphoma

8 registered clinical trials studyying Primary Central Nervous System Hodgkin Lymphoma — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingOrelabrutinib, Sintilimab and Temozolomide in Relapsed or Refractory Central Nervous System Lymphoma
NCT04961515
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 2
CompletedVorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hemato
NCT01789255
National Cancer Institute (NCI)Phase 2
CompletedVaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing
NCT01588015
City of Hope Medical CenterPhase 1
CompletedMK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia
NCT01231919
National Cancer Institute (NCI)Phase 1
CompletedRO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
NCT01158274
National Cancer Institute (NCI)Phase 1
CompletedVorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction
NCT00499811
National Cancer Institute (NCI)Phase 1
Completed3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma
NCT00293345
National Cancer Institute (NCI)Phase 1
CompletedPXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas
NCT00348985
National Cancer Institute (NCI)Phase 1